Biểu đồ giá cổ phiếu HURA
HURA Giá
TuHURA Biosciences Inc
$2.57
15.76%
$0.34
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$2.51
-2.31%
$-0.05
Phiên sau giờ: Jun 18, 20:00:00 GMT-4
Quay lại
TuHURA Biosciences Inc (HURA) Giá
Thống kê chính
Giá đóng cửa trước
$2.22
Giá mở cửa
$2.28
Phạm vi ngày
$2.25 - $2.57
Phạm vi 52 tuần
$0.41 - $3.9
Khối lượng
1.0M
Khối lượng trung bình
1.5M
Tỷ suất cổ tức
0.01%
EPS (TTM)
-0.61
Vốn hóa thị trường
$159.8M
HURA là gì?
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, Florida and currently employs 22 full-time employees. The company went IPO on 2016-07-12. Its lead innate immune agonist, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company has initiated a single randomized placebo-controlled Phase III registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) compared to Keytruda plus placebo in first-line treatment for advanced or metastatic Merkel Cell Carcinoma. The company is leveraging its Delta Opioid Receptor technology to develop bi-specific antibody drug conjugates and antibody peptide conjugates targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. The company is also focused on the novel VISTA inhibiting mAb, known as TBS-2025.
